Method of treating heparin-induced thrombocytopenia
AssigneeEli Lilly and Company
InventorsCharles Jack Fisher, Sau-Chi Betty Yan
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treatment of heparin-induced thrombocytopenia (HIT) with protein C. The claimed invention provides a needed therapy for a potentially serious and debilitating disorder while avoiding complications such as bleeding tendency, toxicity and general side effects of currently available anti-coagulant agents.
Claims4
A method of treating a human patient suffering from heparin-induced thrombocytopenia (HIT) or heparin induced thrombocytopenia and thrombosis syndrome (HITTS) which comprises administering to said patient about 20 μg/kg/hr to about 250 μg/kg/hr of human activated protein C by continuous infusion for 96 hours to about 240 hours.
Dependencies are inferred from the claim text.